Changeflow GovPing Pharma & Drug Safety Patent: Acetyl Glucosamine Improves Cognition
Routine Notice Added

Patent: Acetyl Glucosamine Improves Cognition

Email

Summary

Patent: Acetyl Glucosamine Improves Cognition

Archived snapshot

Apr 12, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Applications

COGNITION

Application US20260097055A1 Kind: A1 Apr 09, 2026

Inventors

Sydney David CULLIS-HILL

Abstract

The present invention relates to acetyl glucosamine. In particular, the present invention relates to the use of acetyl glucosamine to improve cognition.

CPC Classifications

A61K 31/7008 A61P 25/28

Filing Date

2025-12-12

Application No.

19417957

View original document →

Get daily alerts for USPTO Patent Applications - Pharma (A61K)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Instrument
Notice

Get alerts for this source

We'll email you when USPTO Patent Applications - Pharma (A61K) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!